Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +2.4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 3,901–3,950 of 4,268 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01010295	A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae(IELSG27)	completed	Phase 2	54	International Extranodal Lymphoma Study Group (IELSG)OTHER	4	Nov 25, 2013	clinicaltrials
NCT01164267	Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)	completed	Phase 2	30	International Extranodal Lymphoma Study Group (IELSG)